OncoMed Pharmaceuticals Inc (OMED)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: OMED Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2018-12-26 2018-12-24 S Sale

Gurney Austin

See Remarks

Officer
11,117 -14.3%
0.60
6,669 USD 		11,117 -14.3% 0.60 6,669 USD
2018-10-11 2018-10-10 S Sale

Li Yvonne

See Remarks

Officer
927 -1.5%
2.02
1,873 USD 		927 -1.5% 2.02 1,873 USD
2018-10-11 2018-10-10 S Sale

Stagg Robert

SVP, Clinical R&D

Officer
927 -2.2%
2.01
1,863 USD 		927 -2.2% 2.01 1,863 USD
2018-10-11 2018-10-10 S Sale

Lewicki John A.

President & CEO

Executive Director
1,156 -2.0%
2.01
2,324 USD 		1,156 -2.0% 2.01 2,324 USD
2018-10-11 2018-10-10 S Sale

Hager Alicia J.

SVP & General Counsel

Officer
1,156 -2.2%
2.02
2,335 USD 		1,156 -2.2% 2.02 2,335 USD
2018-10-11 2018-10-10 S Sale

Gurney Austin

See Remarks

Officer
1,156 -1.5%
2.01
2,324 USD 		1,156 -1.5% 2.01 2,324 USD
2018-10-10 2018-10-09 S Sale

Stagg Robert

SVP, Clinical R&D

Officer
1,686 -3.9%
2.13
3,589 USD 		1,686 -3.9% 2.13 3,589 USD
2018-10-10 2018-10-09 PS Planned sale

Li Yvonne

See Remarks

Officer
1,229 -2.0%
2.13
2,616 USD 		1,229 -2.0% 2.13 2,616 USD
2018-10-10 2018-10-09 PS Planned sale

Gurney Austin

See Remarks

Officer
1,686 -2.1%
2.13
3,589 USD 		1,686 -2.1% 2.13 3,589 USD
2018-10-10 2018-10-09 PS Planned sale

Lewicki John A.

President & CEO

Executive Director
2,296 -3.9%
2.13
4,888 USD 		2,296 -3.9% 2.13 4,888 USD
2018-10-10 2018-10-09 S Sale

Hager Alicia J.

SVP & General Counsel

Officer
1,686 -3.1%
2.13
3,589 USD 		1,686 -3.1% 2.13 3,589 USD
2018-04-26 2018-04-24 S Sale

Stagg Robert

SVP, Clinical R&D
4,051 -8.6%
2.68
10,848 USD 		4,051 -8.6% 2.68 10,848 USD
2018-04-26 2018-04-24 S Sale

Lewicki John A.

President & CEO

Executive Director
4,557 -7.6%
2.68
12,202 USD 		4,557 -7.6% 2.68 12,202 USD
2018-04-26 2018-04-24 S Sale

Gurney Austin

See Remarks
4,051 -5.0%
2.68
10,848 USD 		4,051 -5.0% 2.68 10,848 USD
2018-04-26 2018-04-24 S Sale

Li Yvonne

See Remarks
5,062 -7.8%
2.68
13,555 USD 		5,062 -7.8% 2.68 13,555 USD
2018-04-26 2018-04-24 S Sale

Hager Alicia J.

SVP & General Counsel
4,051 -6.9%
2.68
10,848 USD 		4,051 -6.9% 2.68 10,848 USD
2017-10-12 2017-10-10 S Sale

Hager Alicia J.

SVP & General Counsel
1,202 -2.0%
4.24
5,099 USD 		1,202 -2.0% 4.24 5,099 USD
2017-10-12 2017-10-10 S Sale

Hager Alicia J.

SVP & General Counsel
46 -0.1%
4.26
196 USD 		46 -0.1% 4.26 196 USD
2017-10-12 2017-10-10 S Sale

Patel Sunil

See Remarks
1,202 -1.7%
4.24
5,099 USD 		1,202 -1.7% 4.24 5,099 USD
2017-10-12 2017-10-10 S Sale

Patel Sunil

See Remarks
46 -0.1%
4.27
196 USD 		46 -0.1% 4.27 196 USD
2017-10-12 2017-10-10 S Sale

HASTINGS PAUL J

Chairman & CEO
1,346 -1.7%
4.24
5,709 USD 		1,346 -1.7% 4.24 5,709 USD
2017-10-12 2017-10-10 S Sale

HASTINGS PAUL J

Chairman & CEO
52 -0.1%
4.26
222 USD 		52 -0.1% 4.26 222 USD
2017-10-12 2017-10-10 S Sale

Gurney Austin

See Remarks
1,202 -1.5%
4.24
5,099 USD 		1,202 -1.5% 4.24 5,099 USD
2017-10-12 2017-10-10 S Sale

Gurney Austin

See Remarks
46 -0.1%
4.27
196 USD 		46 -0.1% 4.27 196 USD
2017-10-12 2017-10-10 S Sale

Lewicki John A.

EVP, Research & Development
1,202 -1.7%
4.24
5,099 USD 		1,202 -1.7% 4.24 5,099 USD
2017-10-12 2017-10-10 S Sale

Lewicki John A.

EVP, Research & Development
46 -0.1%
4.26
196 USD 		46 -0.1% 4.26 196 USD
2017-06-07 2017-06-05 B Purchase

KARSEN PERRY A

10,000 +inf%
3.46
34,588 USD 		10,000 +inf% 3.46 34,588 USD
2017-05-26 2017-05-26 S Sale

ROOT JONATHAN D

Non-Executive Director
3,222 -100.0%
3.70
11,927 USD 		3,222 -100.0% 3.70 11,927 USD
2017-05-26 2017-05-26 S Sale

ROOT JONATHAN D

Non-Executive Director
6,358 -100.0%
3.70
23,536 USD 		6,358 -100.0% 3.70 23,536 USD
2017-05-26 2017-05-25 B Purchase

LASERSOHN JACK W

Non-Executive Director
34,614 +22.9%
3.37
116,639 USD 		34,614 +22.9% 3.37 116,639 USD
2017-05-26 2017-05-24 S Sale

ROOT JONATHAN D

Non-Executive Director
1,447 -31.0%
3.72
5,377 USD 		1,447 -31.0% 3.72 5,377 USD
2017-05-26 2017-05-24 S Sale

ROOT JONATHAN D

Non-Executive Director
2,853 -31.0%
3.72
10,601 USD 		2,853 -31.0% 3.72 10,601 USD
2017-05-25 2017-05-23 B Purchase

LASERSOHN JACK W

Non-Executive Director
20,000 +15.3%
3.55
71,000 USD 		20,000 +15.3% 3.55 71,000 USD
2017-05-22 2017-05-19 S Sale

ROOT JONATHAN D

Non-Executive Director
2,519 -35.0%
3.70
9,324 USD 		2,519 -35.0% 3.70 9,324 USD
2017-05-22 2017-05-19 S Sale

ROOT JONATHAN D

Non-Executive Director
4,968 -35.0%
3.70
18,388 USD 		4,968 -35.0% 3.70 18,388 USD
2017-05-18 2017-05-16 B Purchase

LASERSOHN JACK W

Non-Executive Director
23,507 +21.8%
3.49
82,061 USD 		23,507 +21.8% 3.49 82,061 USD
2017-05-18 2017-05-16 S Sale

ROOT JONATHAN D

Non-Executive Director
2,321 -24.4%
3.58
8,313 USD 		2,321 -24.4% 3.58 8,313 USD
2017-05-18 2017-05-16 S Sale

ROOT JONATHAN D

Non-Executive Director
4,579 -24.4%
3.58
16,401 USD 		4,579 -24.4% 3.58 16,401 USD
2017-04-05 2017-04-04 S Sale

Patel Sunil

See Remarks
5,711 -18.9%
9.06
51,731 USD 		5,711 -18.9% 9.06 51,731 USD
2017-04-05 2017-04-04 S Sale

Patel Sunil

See Remarks
43 -0.1%
8.87
382 USD 		43 -0.1% 8.87 382 USD
2017-04-05 2017-04-04 PS Planned sale

Hoey Timothy

SVP, Cancer Biology & Co-CSO
5,711 -9.1%
9.06
51,731 USD 		5,711 -9.1% 9.06 51,731 USD
2017-04-05 2017-04-04 PS Planned sale

Hoey Timothy

SVP, Cancer Biology & Co-CSO
43 -0.1%
8.87
381 USD 		43 -0.1% 8.87 381 USD
2017-04-05 2017-04-04 S Sale

Hager Alicia J.

SVP & General Counsel
4,284 -16.6%
9.06
38,805 USD 		4,284 -16.6% 9.06 38,805 USD
2017-04-05 2017-04-04 S Sale

Hager Alicia J.

SVP & General Counsel
32 -0.1%
8.87
284 USD 		32 -0.1% 8.87 284 USD
2017-04-05 2017-04-04 PS Planned sale

HASTINGS PAUL J

Chairman & CEO

Executive Director
6,425 -16.5%
9.06
58,199 USD 		6,425 -16.5% 9.06 58,199 USD
2017-04-05 2017-04-04 PS Planned sale

HASTINGS PAUL J

Chairman & CEO

Executive Director
48 -0.1%
8.87
426 USD 		48 -0.1% 8.87 426 USD
2017-04-05 2017-04-04 PS Planned sale

Gurney Austin

See Remarks
5,711 -11.7%
9.06
51,731 USD 		5,711 -11.7% 9.06 51,731 USD
2017-04-05 2017-04-04 PS Planned sale

Gurney Austin

See Remarks
43 -0.1%
8.87
381 USD 		43 -0.1% 8.87 381 USD
2017-04-05 2017-04-04 PS Planned sale

Lewicki John A.

EVP, Research & Development
5,711 -19.9%
9.06
51,731 USD 		5,711 -19.9% 9.06 51,731 USD
2017-04-05 2017-04-04 PS Planned sale

Lewicki John A.

EVP, Research & Development
43 -0.1%
8.87
381 USD 		43 -0.1% 8.87 381 USD
2017-03-17 2017-03-15 PS Planned sale

Hager Alicia J.

SVP & General Counsel
6,652 -20.4%
10.00
66,520 USD 		6,652 -20.4% 10.00 66,520 USD
2017-01-09 2017-01-06 PS Planned sale

HASTINGS PAUL J

Chairman & CEO

Executive Director
21,369 -36.4%
8.52
181,957 USD 		21,369 -36.4% 8.52 181,957 USD
2017-01-09 2017-01-05 PS Planned sale

HASTINGS PAUL J

Chairman & CEO

Executive Director
21,369 -36.4%
8.17
174,602 USD 		21,369 -36.4% 8.17 174,602 USD
2017-01-05 2017-01-03 PS Planned sale

Hoey Timothy

SVP, Cancer Biology & Co-CSO
12,763 -17.3%
7.64
97,448 USD 		12,763 -17.3% 7.64 97,448 USD
2017-01-05 2017-01-03 PS Planned sale

Lewicki John A.

EVP, Research & Development
9,175 -22.5%
7.63
70,045 USD 		9,175 -22.5% 7.63 70,045 USD
2016-11-18 2016-11-16 PS Planned sale

Hoey Timothy

SVP, Cancer Biology & Co-CSO

Officer
12,500 -17.0%
9.89
123,609 USD 		12,500 -17.0% 9.89 123,609 USD
2016-01-12 2016-01-11 PS Planned sale

Dupont Jakob

SVP & Chief Medical Officer

Officer
2,500 -10.8%
20.01
50,021 USD 		2,500 -10.8% 20.01 50,021 USD
2016-01-08 2016-01-07 S Sale

Patel Sunil

See Remarks

Officer
1 -0.0%
21.33
21 USD 		1 -0.0% 21.33 21 USD
2016-01-08 2016-01-07 S Sale

Lewicki John A.

EVP & Chief Scientific Officer

Officer
1 -0.0%
21.33
21 USD 		1 -0.0% 21.33 21 USD
2016-01-08 2016-01-07 S Sale

Dupont Jakob

SVP & Chief Medical Officer

Officer
1 -0.0%
21.33
21 USD 		1 -0.0% 21.33 21 USD
2016-01-08 2016-01-07 S Sale

Hoey Timothy

SVP, Cancer Biology

Officer
1 -0.0%
21.33
21 USD 		1 -0.0% 21.33 21 USD
2016-01-08 2016-01-07 S Sale

Gurney Austin

See Remarks

Officer
1 -0.0%
21.33
21 USD 		1 -0.0% 21.33 21 USD
2016-01-08 2016-01-07 S Sale

Hager Alicia J.

VP & General Counsel

Officer
1 -0.0%
21.33
21 USD 		1 -0.0% 21.33 21 USD
2016-01-08 2016-01-06 PS Planned sale

HASTINGS PAUL J

Chairman & CEO

Executive Director
77 -0.3%
21.54
1,659 USD 		77 -0.3% 21.54 1,659 USD
2016-01-08 2016-01-06 S Sale

Patel Sunil

See Remarks

Officer
69 -0.4%
21.65
1,494 USD 		69 -0.4% 21.65 1,494 USD
2016-01-08 2016-01-06 S Sale

Lewicki John A.

EVP & Chief Scientific Officer

Officer
69 -0.4%
21.56
1,488 USD 		69 -0.4% 21.56 1,488 USD
2016-01-08 2016-01-06 S Sale

Dupont Jakob

SVP & Chief Medical Officer

Officer
69 -0.3%
21.54
1,486 USD 		69 -0.3% 21.54 1,486 USD
2016-01-08 2016-01-06 S Sale

Hoey Timothy

SVP, Cancer Biology

Officer
69 -0.1%
21.56
1,488 USD 		69 -0.1% 21.56 1,488 USD
2016-01-08 2016-01-06 S Sale

Gurney Austin

See Remarks

Officer
69 -0.2%
21.54
1,486 USD 		69 -0.2% 21.54 1,486 USD
2016-01-08 2016-01-06 S Sale

Hager Alicia J.

VP & General Counsel

Officer
52 -0.4%
21.54
1,120 USD 		52 -0.4% 21.54 1,120 USD
2016-01-08 2016-01-06 PS Planned sale

HASTINGS PAUL J

Chairman & CEO

Executive Director
2,335 -9.6%
22.30
52,072 USD 		2,335 -9.6% 22.30 52,072 USD
2016-01-08 2016-01-06 S Sale

Patel Sunil

See Remarks

Officer
2,092 -10.5%
22.30
46,653 USD 		2,092 -10.5% 22.30 46,653 USD
2016-01-08 2016-01-06 S Sale

Lewicki John A.

EVP & Chief Scientific Officer

Officer
2,092 -10.5%
22.30
46,653 USD 		2,092 -10.5% 22.30 46,653 USD
2016-01-08 2016-01-06 S Sale

Dupont Jakob

SVP & Chief Medical Officer

Officer
2,092 -9.2%
22.30
46,653 USD 		2,092 -9.2% 22.30 46,653 USD
2016-01-08 2016-01-06 S Sale

Hoey Timothy

SVP, Cancer Biology

Officer
2,092 -4.2%
22.30
46,653 USD 		2,092 -4.2% 22.30 46,653 USD